Cancer latest info, news, treatment, advice- Mainstream and alternative cancer cures

Nexavar Becomes First And Only Approved Treatment Of Hepatocellular Carcinoma In Europe - Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced that the European Commission has granted marketing authorization to Nexavar(R) (sorafenib) tablets for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar, an oral anti-cancer drug, is the first approved systemic therapy for HCC and the only one shown to significantly improve overall survival in patients with the disease. [click link for full article] [Latest Cancer / Oncology News From Medical News Today.]